Journal profile
Science in China. Series C, Life sciences / Chinese Academy of Sciences
ISSN 1006-9305 · eISSN 1869-1889 · Founded 1996
Science in China. Series C, Life sciences / Chinese Academy of Sciences: impact factor 9.6 (journal website); subscription journal; median 103 days to acceptance (110 articles, last 24 months); community-reported acceptance: easy.
Scope
Aims, scope and focus
By OpenAlex counts of its recent articles, Science in China. Series C, Life sciences / Chinese Academy of Sciences's largest topics are RNA and protein synthesis mechanisms, Photosynthetic Processes and Mechanisms and Plant tissue culture and regeneration, together about 20.1% of its articles. Its main subfields are Molecular Biology and Plant Science. (generated from OpenAlex topic counts and CAS ranking data)
Science China Life Sciences is an academic journal cosponsored by the Chinese Academy of Sciences and the National Natural Science Foundation of China, and published by Science China Press. It is committed to publishing high-quality, original results in both basic and applied Life Science research. Covers a wide range of topics in the field of Life Sciences, including biology, medicine, and agriculture and ecology. It publishes authoritative reviews, high-quality original research papers, insight, letter to the editor, highlight, and news and views.
From the journal's Aims & Scope
Editor-in-chief Xiaofeng CaoPublisher website
Editorial board by country: 117 in mainland China (about 80%); most named Mainland China 117, United States 19, United Kingdom 4, Japan 2, Hong Kong, China 1 (147 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- RNA and protein synthesis mechanismsBiochemistry, Genetics and Molecular Biology7.3%
- Photosynthetic Processes and MechanismsBiochemistry, Genetics and Molecular Biology7.2%
- Plant tissue culture and regenerationBiochemistry, Genetics and Molecular Biology5.6%
- Plant Virus Research StudiesAgricultural and Biological Sciences4.8%
- Plant Molecular Biology ResearchAgricultural and Biological Sciences4.5%
- Virus-based gene therapy researchBiochemistry, Genetics and Molecular Biology4.4%
- Genomics and Phylogenetic StudiesBiochemistry, Genetics and Molecular Biology4.3%
- Plant Stress Responses and ToleranceAgricultural and Biological Sciences4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SCIEScopusMEDLINECASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 9.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 8.8Publisher website ·
- h-index
- 54OpenAlex ·
- i10-index
- 484OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Downloads per year (publisher) 2025
- 932,700Publisher website ·
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
103 daysMedian, submission to acceptance · P25–P75 59 days – 148 days
- Acceptance to online
- median 78 days (110 articles)
- Submission to online
- median 202 days
- Sample
- 110 articles with submission and acceptance dates (740 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
Other charges and waivers (author guidelines)
- Page charges
- Charged; see the journal's website for the amount
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websitePolicy excerpts from the journal's websiteOpen access
- Open access Open access publishing
To find out more about publishing your work Open Access in Science China Life Sciences, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Founded
- 1996
- ISSN
- 1006-9305
- Print ISSN
- 1674-7305
- Electronic ISSN
- 1869-1889
- Latest issue on the website
- Volume 69, Issue 8 (August 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Science in China. Series C, Life sciences / Chinese Academy of Sciences
What is the impact factor of Science in China. Series C, Life sciences / Chinese Academy of Sciences?
The journal's website gives an impact factor of 9.6 (2025); this is the journal's own figure, as LetPub lists none for it; h-index 54.
How long does peer review take at Science in China. Series C, Life sciences / Chinese Academy of Sciences?
Based on the dates recorded on 110 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 103 days (interquartile range 59–148 days); the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Science in China. Series C, Life sciences / Chinese Academy of Sciences based?
Of the 147 board members whose country the journal's board page names, 117 (about 80%) are in mainland China; the countries named most often are Mainland China (117), United States (19) and United Kingdom (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Science in China. Series C, Life sciences / Chinese Academy of Sciences?
The journal's website lists SCIE, Scopus, MEDLINE, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Science in China. Series C, Life sciences / Chinese Academy of Sciences open access, and what is the APC?
Science in China. Series C, Life sciences / Chinese Academy of Sciences is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .